|
|
Article: CHARTER MEDICAL'S CELL-FREEZE APPROVED BY DANA-FARBER.
- Article from:
- Biotech Equipment Update
- Article date:
- August 1, 2009
CopyrightCOPYRIGHT 2009 Worldwide Videotex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Charter Medical, Ltd., a division of Lydall, Inc. (NYSE:LDL), has announced that their 501(k) cleared CELL-FREEZE(r) cryogenic storage containers were approved by Dana-Farber Cancer Institute in Boston, MA. CELL-FREEZE(r) was designed for peripherally derived stem cells and used for cryogenic temperature applications as low as -196 degrees Celsius for storage, preservation and transfer. Dana-Farber Cancer Institute, a national leader in adult and pediatric cancer care and research, will be using CELL-FREEZE(r) for stem cell applications.
Peter Ferris, President of Charter Medical, Ltd. states, "We are pleased Dana-Farber Cancer Institute, a world class cancer ...